PubRank

N C Fox

Author PubWeight™ 120.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet 2013 9.46
2 A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 2009 5.94
3 Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 2005 5.51
4 The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging 1997 3.94
5 Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology 2009 3.49
6 Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol 2001 3.43
7 Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004 3.25
8 Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed 1997 2.56
9 Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images. J Comput Assist Tomogr 1998 2.20
10 Rates of global and regional cerebral atrophy in AD and frontotemporal dementia. Neurology 2001 2.09
11 Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology 2009 1.95
12 Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol 2001 1.94
13 Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology 2009 1.88
14 The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009 1.86
15 Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Neurology 2005 1.73
16 The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology 2006 1.71
17 Early onset familial Alzheimer's disease: Mutation frequency in 31 families. Neurology 2003 1.71
18 Automated hippocampal segmentation by regional fluid registration of serial MRI: validation and application in Alzheimer's disease. Neuroimage 2001 1.71
19 Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet 1999 1.68
20 Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutation. Neurology 2002 1.60
21 A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus. Neuroimage 2008 1.40
22 Brain biopsy in dementia. Brain 2005 1.36
23 Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders. J Comput Assist Tomogr 1996 1.36
24 Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment. Neurology 2007 1.33
25 Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2005 1.33
26 Haemodialysis and cerebral oedema. Nephron 2001 1.33
27 Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology 2001 1.32
28 MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology 2006 1.28
29 Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment. Neurobiol Aging 2010 1.21
30 Acceleration of cortical thinning in familial Alzheimer's disease. Neurobiol Aging 2009 1.18
31 MR image texture analysis applied to the diagnosis and tracking of Alzheimer's disease. IEEE Trans Med Imaging 1998 1.17
32 A volumetric study of hippocampus and amygdala in depressed patients with subjective memory problems. J Neuropsychiatry Clin Neurosci 2000 1.17
33 Epilepsy presenting as AD: neuroimaging, electroclinical features, and response to treatment. Neurology 2002 1.17
34 Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials. J Neurol 2006 1.16
35 Intracranial volume and Alzheimer disease: evidence against the cerebral reserve hypothesis. Arch Neurol 2000 1.16
36 Detection of ventricular enlargement in patients at the earliest clinical stage of MS. Neurology 2000 1.14
37 Onset and progression of pathologic atrophy in Huntington disease: a longitudinal MR imaging study. AJNR Am J Neuroradiol 2010 1.13
38 Tracking progression in frontotemporal lobar degeneration: serial MRI in semantic dementia. Neurology 2008 1.12
39 Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease. Neurology 2009 1.10
40 Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease. AJNR Am J Neuroradiol 2009 1.10
41 Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study. Neurology 2010 1.09
42 Incomplete penetrance of familial Alzheimer's disease in a pedigree with a novel presenilin-1 gene mutation. Lancet 1996 1.07
43 Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors. Neurology 2008 1.05
44 Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging. Neurobiol Aging 2007 1.01
45 Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registration. Neuroimage 2006 1.01
46 Increased rate of whole-brain atrophy over 6 months in early Huntington disease. Neurology 2006 1.00
47 Automatic calculation of hippocampal atrophy rates using a hippocampal template and the boundary shift integral. Neurobiol Aging 2006 0.99
48 Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease. Neurosci Lett 2003 0.99
49 Longitudinal imaging in dementia. Br J Radiol 2007 0.96
50 Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis. J Neurol Neurosurg Psychiatry 2002 0.96
51 EFNS task force: the use of neuroimaging in the diagnosis of dementia. Eur J Neurol 2012 0.95
52 Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities. Neurology 2002 0.95
53 Neuropsychological correlates of whole brain atrophy in Alzheimer's disease. Neuropsychologia 2008 0.95
54 A presenilin 1 R278I mutation presenting with language impairment. Neurology 2004 0.94
55 The application of serial MRI analysis techniques to the study of cerebral atrophy in late-onset dementia. Med Image Anal 2004 0.93
56 Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC. J Neurol Neurosurg Psychiatry 2003 0.93
57 Development of selective verbal memory impairment secondary to a left thalamic infarct: a longitudinal case study. J Neurol Neurosurg Psychiatry 2003 0.92
58 Magnetization transfer ratio in Alzheimer disease: comparison with volumetric measurements. AJNR Am J Neuroradiol 2007 0.90
59 Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration. Int J Geriatr Psychiatry 2003 0.90
60 Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2005 0.88
61 A decade of pre-diagnostic assessment in a case of familial Alzheimer's disease: tracking progression from asymptomatic to MCI and dementia. Neurocase 2005 0.87
62 Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. Neurocase 2005 0.87
63 Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine-->serine (L250S) substitution at codon 250 of the presenilin 1 gene. J Neurol Neurosurg Psychiatry 1998 0.86
64 Comparison of nasal pressure support ventilation with nasal intermittent positive pressure ventilation in patients with nocturnal hypoventilation. Eur Respir J 1993 0.84
65 Distinct neuropsychological profiles correspond to distribution of cortical thinning in inherited prion disease caused by insertional mutation. J Neurol Neurosurg Psychiatry 2011 0.83
66 Missense SNP of the MC1R gene is associated with plumage variation in the Gyrfalcon (Falco rusticolus). Anim Genet 2011 0.83
67 Brain-water diffusion coefficients reflect the severity of inherited prion disease. Neurology 2010 0.83
68 Transient ischaemic attacks are associated with increased rates of global cerebral atrophy. J Neurol Neurosurg Psychiatry 2003 0.82
69 Clinical features of sporadic and familial Alzheimer's disease. Neurodegeneration 1996 0.82
70 Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation: A clinicopathological study. Brain 2000 0.82
71 Pathogenic presenilin 1 mutations (P436S & I143F) in early-onset Alzheimer's disease in the UK. Mutations in brief no. 223. Online. Hum Mutat 1999 0.82
72 Autopsy-confirmed familial early-onset Alzheimer disease caused by the l153V presenilin 1 mutation. Arch Neurol 2001 0.82
73 Slowing the progression of Alzheimer disease: monitoring progression. Alzheimer Dis Assoc Disord 1997 0.81
74 A second family with familial AD and the V717L APP mutation has a later age at onset. Neurology 2006 0.81
75 Memory complaints and increased rates of brain atrophy: risk factors for mild cognitive impairment and Alzheimer's disease. Int J Geriatr Psychiatry 2010 0.81
76 CANDID--Counselling and Diagnosis in Dementia: a national telemedicine service supporting the care of younger patients with dementia. Int J Geriatr Psychiatry 1998 0.80
77 Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004 0.78
78 Familial Alzheimer's disease and inherited prion disease in the UK are poorly ascertained. J Neurol Neurosurg Psychiatry 2010 0.78
79 Do symptoms of memory impairment correspond to cognitive impairment: a cross sectional study of a clinical cohort. Int J Geriatr Psychiatry 2006 0.76
80 An alternative method for estimating efficacy of the AN1792 vaccine for Alzheimer disease. Neurology 2008 0.76
81 Presymptomatic studies in genetic frontotemporal dementia. Rev Neurol (Paris) 2013 0.76
82 An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels. Exp Neurol 2009 0.76
83 Genetics of the dementias. J Neurol Neurosurg Psychiatry 2002 0.75
84 The cultural context of visual hallucinations. Postgrad Med J 2008 0.75
85 Mere forgetfulness or early Alzheimer's disease? Ann Neurol 2000 0.75
86 Knight's move thinking? Mild cognitive impairment in a chess player. Neurocase 2005 0.75
87 Non-Alzheimer dementias in young patients. Br J Psychiatry 1996 0.75
88 Visualisation and quantification of HIV related brain atrophy using registered serial magnetic resonance imaging. Sex Transm Infect 1998 0.75
89 Application of current ultrastructural eggshell quality assessment in captive breeding programmes: observations on hatched and unhatched eggs of the Saker falcon (Falco cherrug). Br Poult Sci 1999 0.75
90 Seeing what Alzheimer saw--with magnetic resonance microscopy. Nat Med 2000 0.75
91 Bacteriological, haematological and clinical chemical studies on the Mauritius kestrel (Falco punctatus). Avian Pathol 1986 0.75